Larimar Therapeutics
LRMR
#7762
Rank
C$0.36 B
Marketcap
$5.77
Share price
0.75%
Change (1 day)
1.75%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.25

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.32. In 2022 the company made an earnings per share (EPS) of -$2.22 an increase over its 2021 EPS that were of -$4.28.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.25-43.82%
2022-$2.22-48.15%
2021-$4.28-14.27%
2020-$4.99